OQROGet OQRO Pro
Insider trade

Ionis Pharmaceuticals (IONS)Director sold ~$322K

Joseph H Wender, Director at Ionis Pharmaceuticals, sold ~$322K of Ionis Pharmaceuticals shares.

~$322K
Approx. value · 5,600 sh @ $57.53
120K
Holds after · shares reported
Traded
Sep 2, 2025
Filed
Sep 5, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 11, 2025InsiderCEO sold ~$48K of IONS shares in the open market
  2. Jul 30, 2025InsiderCEO sold ~$109K of IONS shares in the open market
  3. Aug 4, 2025InsiderOfficer sold ~$409K of IONS shares in the open market
  4. Aug 5, 2025InsiderOfficer sold ~$429K of IONS shares in the open market
  5. Aug 6, 2025Insider · 1 personInsiders: 2 sales (~$210K)
  6. Aug 18, 2025InsiderOfficer sold ~$440K of IONS shares in the open market
  7. Aug 22, 2025InsiderDirector sold ~$61K of IONS shares in the open market
  8. Sep 2, 2025 · this disclosureInsiderDirector sold ~$322K of IONS shares in the open market

What came next

  1. Sep 2, 2025Insider · 6 peopleInsiders: 8 sales (~$3.6M)
  2. Sep 3, 2025Insider · 9 peopleInsiders: 14 sales (~$25.7M)
  3. Sep 5, 2025Insider · 2 peopleInsiders: 2 sales (~$373K)
  4. Sep 9, 2025Insider · 2 peopleInsiders: 3 sales (~$2.1M)
  5. Sep 12, 2025InsiderOfficer sold ~$110K of IONS shares in the open market
  6. Oct 28, 2025Company filing · Form 8-K · Material agreementSigned an important agreement
  7. Oct 29, 2025Company filing · Form 8-K · ResultsReported its results
  8. Nov 11, 2025Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 2 more items)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Ionis Pharmaceuticals

For Ionis Pharmaceuticals, OQRO holds 11 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IONS page.

Other recent filings by Joseph H Wender, Director

The full history of Joseph H Wender, Director is on the profile page.

How this filing works

Other disclosures at Ionis Pharmaceuticals

Everything OQRO holds on this company is on its IONS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data